Lv1
30 积分 2023-12-12 加入
Histologic and immunologic factors associated with response to immune checkpoint inhibitors in advanced sarcoma
3天前
已完结
Association Between Human Epidermal Growth Factor Receptor 2-Low Status and Time to Development of Brain Metastases Among Patients With Breast Cancer: A Retrospective Cohort Study
3天前
已完结
Response to PARP inhibitor in EGFR-tyrosine kinase inhibitor-resistant metastatic lung adenocarcinoma with germline PALB2 mutation
24天前
已完结
中国乳腺癌PIK3CA基因突变检测专家共识(2025版)
1个月前
已完结
BRCA1/2突变和同源重组修复缺陷(HRD)检测在乳腺癌中的临床研究进展
3个月前
已完结
Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report
3个月前
已关闭
Sustained Response to Brigatinib in an Aggressive Relapsing Atypical Pituicytoma With ELM4-ALK Fusion
3个月前
已关闭
靶向叶酸受体α的抗体偶联药物研究进展
3个月前
已完结
[Guideline for HER2 testing in breast cancer (2024 version)]
3个月前
已完结
[Consensus on immunohistochemical detection of PD-L1 (SP263) in bladder invasive urothelial carcinoma]
3个月前
已完结
皖公网安备34019202002308
